
Embryonal cancer can arise from postnatally persistent embryonal remnant or rest cells, which are uniquely characterized by the absence of p53 mutations. Perinatal overexpression of the MycN oncoprotein in embryonal cancer precursor cells causes postnatal rests, and later tumor formation through unknown mechanisms. However, overexpression of Myc in adult tissues normally activates apoptosis and/or senescence signals as an organismal defense mechanism against cancer. Here, we show that perinatal neuroblastoma precursor cells exhibited a transiently diminished p53 response to MycN oncoprotein stress and resistance to trophic factor withdrawal, compared with their adult counterpart cells from the TH-MYCN(+/+) transgenic mouse model of neuroblastoma. The adult stem cell maintenance factor and Polycomb group protein, Bmi1 (B-cell-specific Moloney murine leukemia virus integration site), had a critical role at neuroblastoma initiation in the model, by repressing p53 responses in precursor cells. We further show in neuroblastoma tumor cells that Bmi1 could directly bind p53 in a complex with other Polycomb complex proteins, Ring1A or Ring1B, leading to increased p53 ubiquitination and degradation. Repressed p53 signal responses were also seen in precursor cells for other embryonal cancer types, medulloblastoma and acute lymphoblastic leukemia. Collectively, these date indicate a general mechanism for p53 inactivation in some embryonal cell types and consequent susceptibility to MycN oncogenesis at the point of embryonal tumor initiation.
p53, 32 Biomedical and Clinical Sciences, Apoptosis, anzsrc-for: 1103 Clinical Sciences, Mice, Neuroblastoma, Neoplasms, MYCN, 2.1 Biological and endogenous factors, 1306 Cancer Research, anzsrc-for: 31 Biological Sciences, Polyubiquitin, Cancer, Pediatric, Oncogene Proteins, Polycomb Repressive Complex 1, N-Myc Proto-Oncogene Protein, Tumor, Leukemia, Protein Stability, anzsrc-for: 3101 Biochemistry and Cell Biology, Nuclear Proteins, Proto-Oncogene Proteins c-mdm2, Neoplasms, Germ Cell and Embryonal, Stem-cells, Neoplastic Stem Cells, Stem Cell Research - Nonembryonic - Non-Human, MYC transgenic mice, Signal Transduction, 570, Proteasome Endopeptidase Complex, Pediatric Cancer, Physiological, 610, 3101 Biochemistry and Cell Biology, Stress, Cell Line, Rare Diseases, anzsrc-for: 32 Biomedical and Clinical Sciences, 1311 Genetics, In-vivo, Cell Line, Tumor, Proto-Oncogene Proteins, 616, 1312 Molecular Biology, Animals, Humans, Cyclin-Dependent Kinase Inhibitor p16, anzsrc-for: 3211 Oncology and Carcinogenesis, anzsrc-for: 111403 Paediatrics, Neurosciences, Ubiquitination, anzsrc-for: 1112 Oncology and Carcinogenesis, 3211 Oncology and Carcinogenesis, Stem Cell Research, Bmi1, Proteolysis, Germ Cell and Embryonal, Tumor Suppressor Protein p53, 31 Biological Sciences, Medulloblastoma
p53, 32 Biomedical and Clinical Sciences, Apoptosis, anzsrc-for: 1103 Clinical Sciences, Mice, Neuroblastoma, Neoplasms, MYCN, 2.1 Biological and endogenous factors, 1306 Cancer Research, anzsrc-for: 31 Biological Sciences, Polyubiquitin, Cancer, Pediatric, Oncogene Proteins, Polycomb Repressive Complex 1, N-Myc Proto-Oncogene Protein, Tumor, Leukemia, Protein Stability, anzsrc-for: 3101 Biochemistry and Cell Biology, Nuclear Proteins, Proto-Oncogene Proteins c-mdm2, Neoplasms, Germ Cell and Embryonal, Stem-cells, Neoplastic Stem Cells, Stem Cell Research - Nonembryonic - Non-Human, MYC transgenic mice, Signal Transduction, 570, Proteasome Endopeptidase Complex, Pediatric Cancer, Physiological, 610, 3101 Biochemistry and Cell Biology, Stress, Cell Line, Rare Diseases, anzsrc-for: 32 Biomedical and Clinical Sciences, 1311 Genetics, In-vivo, Cell Line, Tumor, Proto-Oncogene Proteins, 616, 1312 Molecular Biology, Animals, Humans, Cyclin-Dependent Kinase Inhibitor p16, anzsrc-for: 3211 Oncology and Carcinogenesis, anzsrc-for: 111403 Paediatrics, Neurosciences, Ubiquitination, anzsrc-for: 1112 Oncology and Carcinogenesis, 3211 Oncology and Carcinogenesis, Stem Cell Research, Bmi1, Proteolysis, Germ Cell and Embryonal, Tumor Suppressor Protein p53, 31 Biological Sciences, Medulloblastoma
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 61 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
